News

Researchers are working to launch a first-in-human clinical trial to test the approach in patients with cancer who develop ...
There are at least six kinds of diabetes you should know about. Endocrinologists explain the causes, symptoms, and treatments ...
In a US Phase I and II clinical trial evaluating another FcR-nonbinding anti-CD3 antibody (teplizumab or hOKT3γ1 Ala–Ala) at the time of onset of Type 1 diabetes, anti-CD3 treatment halted the ...
Bioresponsive materials have gained prominence as innovative tools for advancing drug delivery systems, particularly in managing type 1 and type 2 diabetes mellitus. These materials respond to ...
Seven consecutive patients (median age, 44 years; range, 29 to 54) who had had type 1 diabetes mellitus for a median of 35 years (range, 18 to 50) underwent islet transplantation between March ...